Here are relevant reports on : biologics-market
-
Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule), Biologics (API, FDF), Packaging & Labelling, Fill-finish), Molecule (Small, Large (ADC, CGT)) - Global Forecast to 2030
The global pharmaceutical contract manufacturing market, valued at US$193.52 billion in 2024, stood at US$209.90 billion in 2025 and is projected to advance at a resilient CAGR of 8.2% from 2025 to 2030, culminating in a forecasted valuation of US$311.95 billion by the end of the period. This is mainly due to the high demand for outsourcing services for GLP-1 manufacturing, the growing ADC outsourcing for commercialized products, and the development and patent expiry of blockbuster biologics, which are paving the way for key biosimilars.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) & Region – Global Forecast to 2027
The global wound care biologics market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.4 billion by 2027, growing at a CAGR of 5.4% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Spine Biologics Market by Product Type (Bone Graft, Bone Graft Substitute, Platelet Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast to 2020
Spinal biologics encompass materials that can be utilized in case of bone fusion surgery, spinal cord injury, and degenerative disk disease. Ten years ago, the spine treatment market constituted 75% traditional rods and plates made of metals and 25% biologics. However, since metals are inert materials, they did not stimulate the bone regeneration process. On the other hand, biological materials are proteins that can attract and stimulate cells, promote fusion, and help in the bone healing process. . The global spine biologics market is expected to reach $2.4 Billion by 2020, at a CAGR of 4.4% during the forecast period from 2015 to 2020.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Top 10 Bioprocess Technology Market by Cell Culture, Cell Expansion, Cell Counting, Cell Line Development, Flow Cytometry, Single-Use Bioprocessing, Biologics Safety Testing, Tangential Flow Filtration, Virus Filtration & Region - Global Forecast to 2021
The global top 10 bioprocess technology market is expected to USD 71.03 Billion by 2021 from USD 39.30 Billion in 2016, at a CAGR of 12.4% between 2016 and 2021. Growth in the biopharmaceutical industry, increase in R&D spending, rising demand for vaccine production, and technological advancements form important growth drivers for this market. On the other hand, stringent regulatory policies and high cost of instruments are restraining market growth for bioprocess technologies.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030
The global drug discovery services market, valued at US$14.89B in 2024, is forecasted to grow at a 10.7% CAGR, reaching US$16.36B by 2025 and US$27.23B by 2030. Growing awareness about personalized medicines and targeted therapies, a vast patient population, and emerging middle-class population are enhancing market penetration in the Asia Pacific region.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs by (CLL, ALL, CML, AML)), Mode of Administration (Oral, Injectable), Molecule Type (Small Molecules, Biologics), Gender, and Region - Global Forecast to 2024
The leukemia therapeutics market is projected to reach USD 17.1 billion by 2024, at a CAGR of 6.8%. Market growth is largely driven by the rising prevalence of acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML) and increasing approvals of novel & innovative drugs and immunotherapies. The major players in this market are AbbVie (US), Bristol-Myers Squibb (US), Novartis (Switzerland, F. Hoffmann-La Roche (Switzerland), Pfizer (US), Sanofi (France), Amgen (US), Gilead Sciences (US), Takeda Pharmaceutical (Japan), and Celgene (US). Product approvals are a key strategy adopted by key players in order to enhance their dominance in this market.
- Published: May 2019
- Price: $ 4950
- TOC Available:
-
Burn Care Market by Product (Advanced (Collagen, Film, Hydrogel, Foam, Alginate Dressings), Therapy Devices (Debridement, NPWT), Biologics, Traditional), Burn Degree (First, Second, Third-degree Burns), End User (Hospitals, ASCs) - Global Forecast to 2030
The global burn care market, valued at US$2.46 billion in 2024, stood at US$2.55 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$3.35 billion by the end of the period. This market is experiencing consistent growth due to several key factors.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Facial Implant Market by Product (Chin, Nasal, Malar, Jaw, Injectable), Material (Metal, Biologics, Polymers, Ceramics, Silicon), Shape (Anatomical, Oval, Round), Procedure (Rhinoplasty, Rhytidectomy, Chin Augmentation, Eyelid, Cheekbone, Forehead), End User (Hospitals, ASCs) - Global Forecasts to 2027
The global facial implants market is projected to reach USD 4.2 billion by 2027 from USD 2.7 Billion in 2022, at a CAGR of 8% during the forecast period. The technological advancements majorly drive the growth in the facial implants market, the growing adoption of minimally invasive aesthetic procedures, the rising popularity of cosmetic procedures, and an increasing number of trauma cases and road accidents.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Human Insulin Market By Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Global Forecast to 2020
The global human insulin market size is projected to grow at a CAGR of 8.1%. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of this market.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Document Management Systems Market by Offering (Solutions, Services), Deployment Mode (On-Premise, Cloud-Based, and Hybrid), Organization (Small & Medium-Sized Enterprise, Large Enterprise), Application, and Geography - Global Forecast to 2023
The document management systems market is expected to reach USD 6.78 Billion by 2023 from USD 3.59 Billion in 2017, at a CAGR of 11.17% during the forecast period. Growth in this market is mainly driven by factors such as the increasing need to streamline business operations, benefits of digitalizing content across enterprises, and the increasing need to adhere to compliance requirements. Some key players in this region include OpenText Corporation (Canada), Xerox Corporation (US), IBM Corporation (US), eFileCabinet Inc. (US), SpringCM (US), Oracle Corporation (US), and Hyland Software Inc. (US).
- Published: December 2017
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
